Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 2, 2011, Pages 230-238

  Boogers, Mark J ^a,b   Chen, Ji ^c   Van Bommel, Rutger J ^a   Borleffs, C Jan Willem ^a   Dibbets Schneider, Petra ^a   Van Der Hiel, Bernies ^a   Al Younis, Imad ^a   Schalij, Martin J ^a   Van Der Wall, Ernst E ^a   Garcia, Ernest V ^c   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CRT; LV lead; Phase analysis; Site of latest mechanical activation; SPECT

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; FLUOROSCOPY; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; BIOMECHANICS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL PERFUSION IMAGING; TREATMENT OUTCOME;

EID: 79551582039     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1621-z     Document Type: Article

References (28)

1. SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats, et al. 2009 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 e391 e479 10.1161/CIRCULATIONAHA.109.192065 19324966
2. AE Epstein JP DiMarco KA Ellenbogen NA Estes III RA Freedman LS Gettes, et al. 2008 ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 21 e350 e408 10.1161/CIRCUALTIONAHA.108.189742 18483207 (Pubitemid 351771339)
3. S Cazeau C Leclercq T Lavergne S Walker C Varma, et al. 2001 Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 12 873 80 1:STN:280:DC%2BD3M7nsV2ltw%3D%3D 10.1056/NEJM200103223441202 11259720 (Pubitemid 32224395)
4. WT Abraham WG Fisher AL Smith DB Delurgio AR Leon E Loh, et al. 2002 Cardiac resynchronization in chronic heart failure N Engl J Med 346 24 1845 53 10.1056/NEJMoa013168 12063368 (Pubitemid 34603028)
5. MR Bristow LA Saxon J Boehmer S Krueger DA Kass MT De, et al. 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 21 2140 50 1:CAS:528:DC%2BD2cXktF2isrc%3D 10.1056/NEJMoa032423 15152059 (Pubitemid 38637994)
6. JG Cleland JC Daubert E Erdmann N Freemantle D Gras L Kappenberger, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 15 1539 49 1:CAS:528:DC%2BD2MXjtFGnsLo%3D 10.1056/NEJMoa050496 15753115 (Pubitemid 40517094)
7. JJ Bax T Abraham SS Barold OA Breithardt JW Fung S Garrigue, et al. 2005 Cardiac resynchronization therapy: Part 1-issues before device implantation J Am Coll Cardiol 46 12 2153 67 10.1016/j.jacc.2005.09.019 16360042 (Pubitemid 41785481)
8. JJ Bax T Abraham SS Barold OA Breithardt JW Fung S Garrigue, et al. 2005 Cardiac resynchronization therapy: part 2-issues during and after device implantation and unresolved questions J Am Coll Cardiol 46 12 2168 82 10.1016/j.jacc.2005.09.020 16360043 (Pubitemid 41785482)
9. C Butter A Auricchio C Stellbrink E Fleck J Ding Y Yu, et al. 2001 Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients Circulation 104 25 3026 9 1:STN:280:DC%2BD3MjgtVKguw%3D%3D 10.1161/hc5001.102229 11748094
10. G Ansalone P Giannantoni R Ricci P Trambaiolo F Fedele M Santini 2002 Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing J Am Coll Cardiol 39 3 489 99 10.1016/S0735-1097(01)01772-7 11823088 (Pubitemid 34117507)
11. M Gasparini M Mantica P Galimberti M Bocciolone L Genovese M Mangiavacchi, et al. 2003 Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin Electrophysiol 26 1 Pt 2 162 8 10.1046/j.1460-9592.2003.00009.x 12687805
12. AL Dekker B Phelps B Dijkman T van der Nagel FH van Veen GG Geskes, et al. 2004 Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops J Thorac Cardiovasc Surg 127 6 1641 1647 1:STN:280:DC%2BD2c3nsVantA%3D%3D 10.1016/j.jtcvs.2003.10.052 15173718 (Pubitemid 38725442)
13. RE Lane AW Chow J Mayet DP Francis NS Peters RJ Schilling, et al. 2007 The interaction of interventricular pacing intervals and left ventricular lead position during temporary biventricular pacing evaluated by tissue Doppler imaging Heart 93 11 1426 32 1:STN:280:DC%2BD2sngvVKmsw%3D%3D 10.1136/hrt.2006.087445 17277351 (Pubitemid 351480147)
14. C Ypenburg RJ Van Bommel V Delgado SA Mollema GB Bleeker E Boersma, et al. 2008 Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy J Am Coll Cardiol 52 17 1402 9 10.1016/j.jacc.2008.06.046 18940531
15. RT Murphy G Sigurdsson S Mulamalla D Agler ZB Popovic RC Starling, et al. 2006 Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy Am J Cardiol 97 11 1615 21 10.1016/j.amjcard.2005.12.054 16728225 (Pubitemid 43737035)
16. M Becker R Kramann A Franke OA Breithardt N Heussen C Knackstedt, et al. 2007 Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography Eur Heart J 28 10 1211 20 10.1093/eurheartj/ehm034 17426079 (Pubitemid 47343834)
17. J Chen EV Garcia RD Folks CD Cooke TL Faber EL Tauxe, et al. 2005 Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony J Nucl Cardiol 12 6 687 95 10.1016/j.nuclcard.2005.06.088 16344231 (Pubitemid 43033609)
18. J Chen MM Henneman MA Trimble JJ Bax S Borges-Neto AE Iskandrian, et al. 2008 Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging J Nucl Cardiol 15 1 127 36 10.1016/j.nuclcard.2007.11.004 18242490 (Pubitemid 351187497)
19. JJ Bax GB Bleeker TH Marwick SG Molhoek E Boersma P Steendijk, et al. 2004 Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy J Am Coll Cardiol 44 9 1834 40 10.1016/j.jacc.2004. 08.016 15519016 (Pubitemid 39424084)
20. MD Cerqueira NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey, et al. 2002 Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 4 539 42 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
21. EJ Hoffman SC Huang ME Phelps 1979 Quantitation in positron emission computed tomography: 1. Effect of object size J Comput Assist Tomogr 3 3 299 308 1:STN:280:DyaE1M7ntlGhtQ%3D%3D 10.1097/00004728-197906000-00001 438372
22. JR Galt EV Garcia WL Robbins 1990 Effects of myocardial wall thickness on SPECT quantification IEEE Trans Med Imaging 9 2 144 50 1:STN:280: DC%2BD1c%2FmslOhsA%3D%3D 10.1109/42.56338 18222758 (Pubitemid 20724994)
23. MS Suffoletto K Dohi M Cannesson S Saba J Gorcsan III 2006 Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy Circulation 113 7 960 8 10.1161/CIRCULATIONAHA.105. 571455 16476850 (Pubitemid 43879471)
24. NB Schiller PM Shah M Crawford A DeMaria R Devereux H Feigenbaum, et al. 1989 Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 5 358 67 1:STN:280:DyaK3c7pvVelsw%3D%3D 2698218
25. RO Bonow BA Carabello K Chatterjee AC de Leon Jr DP Faxon MD Freed, et al. 2008 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 15 e523 661 10.1161/CIRCULATIONAHA.108.190748 18820172
26. GB Bleeker TA Kaandorp HJ Lamb E Boersma P Steendijk A de Roos 2006 Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy Circulation 113 7 969 76 10.1161/CIRCULATIONAHA.105.543678 16476852 (Pubitemid 43879472)
27. C Ypenburg MJ Schalij GB Bleeker P Steendijk E Boersma P Dibbets-Schneider, et al. 2006 Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients J Nucl Med 47 10 1565 70 17015888
28. C Ypenburg MJ Schalij GB Bleeker P Steendijk E Boersma P Dibbets-Schneider, et al. 2007 Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients Eur Heart J 28 1 33 41 10.1093/eurheartj/ehl379 17121757 (Pubitemid 46134955)